Page 6 - Buzzing Stock

Capacit'e Infraprojects bags ₹295-cr project, stock gains 3%; details

The company received a Letter of Acceptance (LoA) from Indus Co-operative Housing Society for a total contract value of ₹295 crore

Here is why Swiggy shares were buzzing in trade on Wednesday, April 16

Swiggy has signed a Memorandum of Understanding (MoU) with the Ministry of Labour & Employment as part of its overall approach to increase job creation through public-private partnership

Muthoot Finance slips 14% in 2 days on RBI's new rules for gold loans

The Reserve Bank of India has proposed new rules to streamline gold loan practices, aiming to bring more transparency and control as lending in this segment grows rapidly.

Cipla share price jumps 5% as USFDA okays cancer drug Paclitaxel

Cipla said USFDA has approved the ANDA submitted for Paclitaxel Protein-bound Particles for Injectable Suspension (albumin-bound), 100 mg/vial, Single-Dose Vial ('Protein-bound Paclitaxel') on Apr 10

Tata Consumer jumps 8% in trade; Goldman Sachs upgrades to 'Buy'; check TP

Goldman Sachs believes the company is poised for strong earnings per share (EPS) growth over FY25-27

Shri Ahimsa Naturals post solid debut, shares list at 18% premium

Shri Ahimsa Naturals shares listed at Rs 140 apiece on the NSE SME, reflecting a premium of ₹21 or 17.65 per cent over the issue price of Rs 119 per share

Active Infrastructures shares list flat at ₹181 apiece on NSE SME

Active Infrastructures IPO listing came almost in line with the grey market estimates. The company's shares listed at ₹181 per share, matching the issue price

Laxmi Dental share price advances 5% as Nuvama initiates with 'Buy' rating

The northward move in the Laxmi Dental share price came after domestic brokerage Nuvama initiated coverage on the stock with a 'Buy' rating.

Stock market closing bell: IT defies market trends, benchmarks settle flat

The IT sector defied the market's trend by adding gains, driven by positive global cues stemming from expectations of softer tariffs and a recent correction in valuations

Biocon gains 2% on US FDA nod for ANDA Norepinephrine Bitartrate Injection

The company's subsidiary has received approval from the US Food and Drug Administration (US FDA) for its ANDA Norepinephrine Bitartrate Injection USP, 4 mg/4 mL (1 mg/mL) single-dose vial

Gland Pharma jumps 6% on multiple bulk deals; check buyers' detail here

According to NSE bulk deal data, Vanguard Emerging Markets Stock Index Fund A Series of VIEIF purchased 0.83 million shares

Ola Electric shares surge 5% after reassuring investors on 'strong' sales

Shares of the electric vehicle maker have fallen 15 per cent this year, compared to a 1.6 per cent fall in the benchmark Nifty 50

Here's why this state-owned railway stock climbed 4% in trade on March 18

RITES share price climbed 3.84 per cent to an intra-day high of Rs 212.25 per share on the BSE during intra-day deals on Tuesday

Hexaware Tech tumbles 7% after reporting December quarter results; Details

Shares of the company were under pressure, after the company reported its first quarterly result, for the quarter ended December 2024, after listing on the bourses

Metropolis up 3% on plans to foray into Western UP with Scientific deal

Metropolis Healthcare plans to acquire Western UP-based Scientific Pathology on a slump sale basis

NTPC share price advances 3% on nuclear power expansion news; details here

The northward movement in the share price came following the news that the Maharatna company is looking to build 30 gigawatts of nuclear power capacity over the next two decades

Welspun Corp shares slip 3% after Q3 revenue takes a hit, declines 24% YoY

The report showed Welspun Corp's consolidated net profit increased 181 per cent at Rs 674.7 crore as compared to Rs 291.86 crore a year ago

Bosch slips 6% after posting Q3 results; here's what's dragging stock

Bosch reported a 12 per cent decrease in consolidated net profit of Rs 458 crore as compared to a profit of Rs 518 crore a year ago

Tata Group stocks zoom up to 12% on reports of Tata Capital's Rs 15K-cr IPO

Tata Group companies' shares increased following reports of Tata Capital planning to raise Rs 15,000 crore through an initial public offering (IPO)

Sagility hits all time high in trade; JP Morgan 'Overweight' on stock

JP Morgan initiated coverage on Sagility with an 'Overweight' rating with a 12-month target price of Rs 54 per share